XOMA Royalty Toekomstige groei
Future criteriumcontroles 5/6
De verwachting is dat XOMA Royalty de winst en omzet met respectievelijk 78% en 31.3% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 78.6% per jaar.
Belangrijke informatie
78.0%
Groei van de winst
78.6%
Groei van de winst per aandeel
Biotechs winstgroei | 28.4% |
Inkomstengroei | 31.3% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 08 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties
Oct 15News Flash: Analysts Just Made A Notable Upgrade To Their XOMA Royalty Corporation (NASDAQ:XOMA) Forecasts
Aug 14Health Check: How Prudently Does XOMA Royalty (NASDAQ:XOMA) Use Debt?
Aug 02XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares
Jun 29Is XOMA (NASDAQ:XOMA) Using Debt Sensibly?
Apr 03Are Investors Undervaluing XOMA Corporation (NASDAQ:XOMA) By 49%?
Sep 01Bearish: Analysts Just Cut Their XOMA Corporation (NASDAQ:XOMA) Revenue and EPS estimates
Aug 11XOMA GAAP EPS of -$0.53 misses by $0.37, revenue of $0.98M misses by $3.29M
Aug 04Forecast: Analysts Think XOMA Corporation's (NASDAQ:XOMA) Business Prospects Have Improved Drastically
May 08Xoma Gets The Spotlight
Sep 02Things Look Grim For XOMA Corporation (NASDAQ:XOMA) After Today's Downgrade
Aug 20We Think The Compensation For XOMA Corporation's (NASDAQ:XOMA) CEO Looks About Right
May 13Does XOMA (NASDAQ:XOMA) Have A Healthy Balance Sheet?
May 11XOMA EPS misses by $0.55, misses on revenue
May 06XOMA gets milestone payment from Janssen Biotech
May 03XOMA's (NASDAQ:XOMA) Earnings Are Of Questionable Quality
Mar 17Analysts Are More Bearish On XOMA Corporation (NASDAQ:XOMA) Than They Used To Be
Mar 16Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions?
Mar 09Did You Miss XOMA's (NASDAQ:XOMA) Impressive 140% Share Price Gain?
Feb 02XOMA: A Royalty Aggregator To Watch
Jan 04XOMA (NASDAQ:XOMA) Has Debt But No Earnings; Should You Worry?
Dec 29XOMA prices $22M offering of series A cumulative perpetual preferred stock
Dec 11Could The XOMA Corporation (NASDAQ:XOMA) Ownership Structure Tell Us Something Useful?
Dec 01Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 49 | 3 | N/A | N/A | 3 |
12/31/2025 | 36 | -7 | N/A | N/A | 3 |
12/31/2024 | 28 | -6 | N/A | N/A | 3 |
9/30/2024 | 22 | -35 | -15 | -15 | N/A |
6/30/2024 | 15 | -24 | -8 | -8 | N/A |
3/31/2024 | 6 | -42 | -13 | -18 | N/A |
12/31/2023 | 5 | -46 | -18 | -18 | N/A |
9/30/2023 | 4 | -32 | -18 | -18 | N/A |
6/30/2023 | 4 | -31 | -20 | -20 | N/A |
3/31/2023 | 3 | -30 | -14 | -17 | N/A |
12/31/2022 | 6 | -23 | -13 | -13 | N/A |
9/30/2022 | 40 | 10 | 42 | 22 | N/A |
6/30/2022 | 41 | 10 | 36 | 22 | N/A |
3/31/2022 | 41 | 12 | 36 | 23 | N/A |
12/31/2021 | 38 | 8 | 23 | 23 | N/A |
9/30/2021 | 30 | 1 | -11 | 10 | N/A |
6/30/2021 | 29 | 6 | -3 | 10 | N/A |
3/31/2021 | 29 | 6 | -2 | 11 | N/A |
12/31/2020 | 29 | 9 | 10 | 10 | N/A |
9/30/2020 | 2 | -13 | -12 | -12 | N/A |
6/30/2020 | 11 | -9 | -18 | -5 | N/A |
3/31/2020 | 11 | -10 | -25 | -6 | N/A |
12/31/2019 | 18 | -2 | -20 | 0 | N/A |
9/30/2019 | 20 | -2 | -18 | 1 | N/A |
6/30/2019 | 12 | -8 | -27 | -5 | N/A |
3/31/2019 | 13 | -6 | -21 | -6 | N/A |
12/31/2018 | 5 | -13 | -28 | -13 | N/A |
9/30/2018 | 9 | -11 | -30 | -15 | N/A |
6/30/2018 | 44 | 9 | N/A | 18 | N/A |
3/31/2018 | 53 | 18 | N/A | 13 | N/A |
12/31/2017 | 53 | 6 | N/A | 3 | N/A |
9/30/2017 | 48 | -11 | N/A | 15 | N/A |
6/30/2017 | 12 | -39 | N/A | -28 | N/A |
3/31/2017 | 2 | -61 | N/A | -32 | N/A |
12/31/2016 | 6 | -54 | N/A | -34 | N/A |
9/30/2016 | 53 | -11 | N/A | -12 | N/A |
6/30/2016 | 55 | 1 | N/A | -19 | N/A |
3/31/2016 | 57 | -7 | N/A | -23 | N/A |
12/31/2015 | 55 | -21 | N/A | -31 | N/A |
9/30/2015 | 12 | -53 | N/A | -77 | N/A |
6/30/2015 | 15 | -67 | N/A | -74 | N/A |
3/31/2015 | 18 | -55 | N/A | -74 | N/A |
12/31/2014 | 19 | -38 | N/A | -78 | N/A |
9/30/2014 | 27 | -83 | N/A | -68 | N/A |
6/30/2014 | 28 | -99 | N/A | -65 | N/A |
3/31/2014 | 29 | -104 | N/A | -60 | N/A |
12/31/2013 | 35 | -124 | N/A | -46 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat XOMA de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.6% ).
Winst versus markt: Er wordt verwacht dat XOMA de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat XOMA binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van XOMA ( 31.3% per jaar) zal naar verwachting sneller groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van XOMA ( 31.3% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van XOMA naar verwachting over 3 jaar hoog zal zijn